MedTrace Logo

Perceptions and Representations of Vaccination Against COVID-19

NCT04896957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2022-12-02

No results posted yet for this study

Summary

SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high:

According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19.

To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.

Conditions

  • COVID-19 Acute Respiratory Distress Syndrome

Interventions

BEHAVIORAL

Interview

Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Villeneuve Saint Georges

    collaborator UNKNOWN

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04896957 on ClinicalTrials.gov